| 1 |
Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2013, 13(5): 426-435.
|
| 2 |
降钙素原急诊临床应用专家共识组. 降钙素原(PCT)急诊临床应用的专家共识[J]. 中华急诊医学杂志，2012, 21(9): 944-951.
|
| 3 |
Maruna P, Nedelníková K, Gürlich R. Physiology and genetics of procalcitonin[J]. Physiol Res, 49(Suppl 1): S57-S61.
|
| 4 |
季娟娟，孙耕耘. 降钙素原和常用炎症指标在脓毒症诊断及预后中的价值[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(4): 416-420.
|
| 5 |
高占成. 降钙素原对诊断慢性阻塞性肺疾病急性加重的应用价值[J]. 中华结核和呼吸杂志，2013, 36(4): 313-314.
|
| 6 |
张立，徐婷，林勇. 降钙素原指导抗生素治疗策略在社区获得性下呼吸道感染中应用的荟萃分析[J]. 中华结核和呼吸杂志，2012, 35(4): 275-282.
|
| 7 |
Bihan H, Becker KL, Snider RH, et al. Calcitonin precursor levels in human medullary thyroid carcinoma[J]. Thyroid, 2003, 13(8): 819-822.
|
| 8 |
Bolko P, Manuszewska-Jopek E, Michaek K, et al. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma[J]. Arch Immunol Ther Exp (Warsz), 2003, 51(6): 415-419.
|
| 9 |
Ittner L, Born W, Rau B, et al. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma[J]. Eur J Endocrinol, 2003, 14(6): 727-731.
|
| 10 |
陈玥，武抗美，金晔. 血清降钙素追查甲状腺髓样癌一例临床报道[J]. 标记免疫分析与临床，2006, 13(1): 56-56.
|
| 11 |
赵岚，崔天盆，张家衡，等. 甲状腺髓样癌血清降钙素原异常增高[J]. 中华检验医学杂志，2015, 38(4): 283-284.
|
| 12 |
Hahm J, Lee M, Min Y, et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases[J]. Thyroid , 2001, 11(1): 73-80.
|